Carregant...
Quality of outcome reporting in phase II studies in pulmonary tuberculosis
Tuberculosis (TB) remains a major killer amongst the infectious diseases. Current treatment involves a four-drug regimen for at least 6 months. New drugs and regimens are required to shorten treatment duration, reduce toxicity and combat drug resistance, but the optimal methodology to define the cri...
Guardat en:
| Publicat a: | Trials |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4644328/ https://ncbi.nlm.nih.gov/pubmed/26566930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-1050-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|